LY 04008
Alternative Names: LY-04008Latest Information Update: 16 Jul 2016
At a glance
- Originator Luye Pharma Group
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Liver disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Liver-disorders in China